nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits
|
Van Heetvelde, Mattias |
|
2018 |
425 |
C |
p. 125-133 |
artikel |
2 |
A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma
|
Liu, Wan-Ting |
|
2018 |
425 |
C |
p. 43-53 |
artikel |
3 |
Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer
|
Virani, Needa A. |
|
2018 |
425 |
C |
p. 174-182 |
artikel |
4 |
ASC-J9® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3
|
Lin, WanYing |
|
2018 |
425 |
C |
p. 21-30 |
artikel |
5 |
Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma
|
Koikawa, Kazuhiro |
|
2018 |
425 |
C |
p. 65-77 |
artikel |
6 |
Circular RNAs (circRNAs) in cancer
|
Zhou, Ruoyu |
|
2018 |
425 |
C |
p. 134-142 |
artikel |
7 |
CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance
|
Hu, Xiaojia |
|
2018 |
425 |
C |
p. 1-12 |
artikel |
8 |
Editorial Board
|
|
|
2018 |
425 |
C |
p. ii |
artikel |
9 |
IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness
|
Xu, Wen Wen |
|
2018 |
425 |
C |
p. 88-100 |
artikel |
10 |
Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation
|
Chen, Yu-Li |
|
2018 |
425 |
C |
p. 152-163 |
artikel |
11 |
Immunotherapy for pancreatic cancer: A long and hopeful journey
|
Xu, Jian-wei |
|
2018 |
425 |
C |
p. 143-151 |
artikel |
12 |
Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression
|
Jiang, Hao |
|
2018 |
425 |
C |
p. 78-87 |
artikel |
13 |
MicroRNAs in type 2 immunity
|
Johansson, Kristina |
|
2018 |
425 |
C |
p. 116-124 |
artikel |
14 |
RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide
|
Lu, Bin |
|
2018 |
425 |
C |
p. 31-42 |
artikel |
15 |
Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells
|
Zanotto-Filho, Alfeu |
|
2018 |
425 |
C |
p. 101-115 |
artikel |
16 |
Squalene epoxidase as a promising metabolic target in cancer treatment
|
Cirmena, Gabriella |
|
2018 |
425 |
C |
p. 13-20 |
artikel |
17 |
Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma
|
Yin, Haisen |
|
2018 |
425 |
C |
p. 54-64 |
artikel |
18 |
Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21Cip1/Waf1, p27Kip1 and cyclin D1
|
Singh, Karnika |
|
2018 |
425 |
C |
p. 164-173 |
artikel |